Acute Bacterial Skin and Skin Structure Infections Market Size, Trends, Analysis, and Outlook By Infection Type (Hospital-acquired ABSSI, Community-acquired ABSSI), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
The global Acute Bacterial Skin and Skin Structure Infections market size is poised to register 8.1% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Acute Bacterial Skin and Skin Structure Infections market across By Infection Type (Hospital-acquired ABSSI, Community-acquired ABSSI), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies).
The acute bacterial skin and skin structure infections (ABSSSI) market is witnessing notable growth driven by the increasing incidence of bacterial infections, rising antibiotic resistance, and advancements in infectious disease diagnostics and therapeutics. In 2024 and beyond, factors such as the growing demand for broad-spectrum antibiotics and novel antimicrobial agents, expansion of wound care management programs, and rising prevalence of healthcare-associated infections drive market expansion. Additionally, the development of rapid diagnostic tests for bacterial identification, integration of combination therapies for multidrug-resistant infections, and collaborations between pharmaceutical companies and infectious disease specialists contribute to market growth.
Acute Bacterial Skin and Skin Structure Infections Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Acute Bacterial Skin and Skin Structure Infections market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Acute Bacterial Skin and Skin Structure Infections survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Acute Bacterial Skin and Skin Structure Infections industry.
Key market trends defining the global Acute Bacterial Skin and Skin Structure Infections demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Acute Bacterial Skin and Skin Structure Infections Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Acute Bacterial Skin and Skin Structure Infections industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Acute Bacterial Skin and Skin Structure Infections companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Acute Bacterial Skin and Skin Structure Infections industry
Leading Acute Bacterial Skin and Skin Structure Infections companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Acute Bacterial Skin and Skin Structure Infections companies.
Acute Bacterial Skin and Skin Structure Infections Market Study- Strategic Analysis Review
The Acute Bacterial Skin and Skin Structure Infections market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Acute Bacterial Skin and Skin Structure Infections industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Acute Bacterial Skin and Skin Structure Infections Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Acute Bacterial Skin and Skin Structure Infections market segments. Similarly, Strong end-user demand is encouraging Canadian Acute Bacterial Skin and Skin Structure Infections companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Acute Bacterial Skin and Skin Structure Infections market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Acute Bacterial Skin and Skin Structure Infections Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Acute Bacterial Skin and Skin Structure Infections industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Acute Bacterial Skin and Skin Structure Infections market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Acute Bacterial Skin and Skin Structure Infections in Asia Pacific. In particular, China, India, and South East Asian Acute Bacterial Skin and Skin Structure Infections markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Acute Bacterial Skin and Skin Structure Infections Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Acute Bacterial Skin and Skin Structure Infections market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Acute Bacterial Skin and Skin Structure Infections.
Acute Bacterial Skin and Skin Structure Infections Market Company Profiles
The global Acute Bacterial Skin and Skin Structure Infections market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Paratek Pharmaceuticals Inc, Melinta Therapeutics Inc, Allergan PLC, Merck & Co. Inc, Endo Pharmaceuticals Inc, Nabriva Therapeutics PLC, Basilea Pharmaceutica Ltd, Cipher Pharmaceuticals, Menarini Group, Sandoz Inc, Glenmark Pharmaceuticals Ltd, Pfizer Inc
Recent Acute Bacterial Skin and Skin Structure Infections Market Developments
The global Acute Bacterial Skin and Skin Structure Infections market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Acute Bacterial Skin and Skin Structure Infections Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographical Segmentation:
Paratek Pharmaceuticals Inc
Melinta Therapeutics Inc
Allergan PLC
Merck & Co. Inc
Endo Pharmaceuticals Inc
Nabriva Therapeutics PLC
Basilea Pharmaceutica Ltd
Cipher Pharmaceuticals
Menarini Group
Sandoz Inc
Glenmark Pharmaceuticals Ltd
Pfizer Inc
Formats Available: Excel, PDF, and PPT
The acute bacterial skin and skin structure infections (ABSSSI) market is witnessing notable growth driven by the increasing incidence of bacterial infections, rising antibiotic resistance, and advancements in infectious disease diagnostics and therapeutics. In 2024 and beyond, factors such as the growing demand for broad-spectrum antibiotics and novel antimicrobial agents, expansion of wound care management programs, and rising prevalence of healthcare-associated infections drive market expansion. Additionally, the development of rapid diagnostic tests for bacterial identification, integration of combination therapies for multidrug-resistant infections, and collaborations between pharmaceutical companies and infectious disease specialists contribute to market growth.
Acute Bacterial Skin and Skin Structure Infections Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Acute Bacterial Skin and Skin Structure Infections market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Acute Bacterial Skin and Skin Structure Infections survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Acute Bacterial Skin and Skin Structure Infections industry.
Key market trends defining the global Acute Bacterial Skin and Skin Structure Infections demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Acute Bacterial Skin and Skin Structure Infections Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Acute Bacterial Skin and Skin Structure Infections industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Acute Bacterial Skin and Skin Structure Infections companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Acute Bacterial Skin and Skin Structure Infections industry
Leading Acute Bacterial Skin and Skin Structure Infections companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Acute Bacterial Skin and Skin Structure Infections companies.
Acute Bacterial Skin and Skin Structure Infections Market Study- Strategic Analysis Review
The Acute Bacterial Skin and Skin Structure Infections market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Acute Bacterial Skin and Skin Structure Infections industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Acute Bacterial Skin and Skin Structure Infections Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Acute Bacterial Skin and Skin Structure Infections market segments. Similarly, Strong end-user demand is encouraging Canadian Acute Bacterial Skin and Skin Structure Infections companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Acute Bacterial Skin and Skin Structure Infections market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Acute Bacterial Skin and Skin Structure Infections Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Acute Bacterial Skin and Skin Structure Infections industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Acute Bacterial Skin and Skin Structure Infections market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Acute Bacterial Skin and Skin Structure Infections in Asia Pacific. In particular, China, India, and South East Asian Acute Bacterial Skin and Skin Structure Infections markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Acute Bacterial Skin and Skin Structure Infections Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Acute Bacterial Skin and Skin Structure Infections market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Acute Bacterial Skin and Skin Structure Infections.
Acute Bacterial Skin and Skin Structure Infections Market Company Profiles
The global Acute Bacterial Skin and Skin Structure Infections market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Paratek Pharmaceuticals Inc, Melinta Therapeutics Inc, Allergan PLC, Merck & Co. Inc, Endo Pharmaceuticals Inc, Nabriva Therapeutics PLC, Basilea Pharmaceutica Ltd, Cipher Pharmaceuticals, Menarini Group, Sandoz Inc, Glenmark Pharmaceuticals Ltd, Pfizer Inc
Recent Acute Bacterial Skin and Skin Structure Infections Market Developments
The global Acute Bacterial Skin and Skin Structure Infections market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Acute Bacterial Skin and Skin Structure Infections Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Paratek Pharmaceuticals Inc
Melinta Therapeutics Inc
Allergan PLC
Merck & Co. Inc
Endo Pharmaceuticals Inc
Nabriva Therapeutics PLC
Basilea Pharmaceutica Ltd
Cipher Pharmaceuticals
Menarini Group
Sandoz Inc
Glenmark Pharmaceuticals Ltd
Pfizer Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Acute Bacterial Skin and Skin Structure Infections Market Overview and Key Findings, 2024
1.2 Acute Bacterial Skin and Skin Structure Infections Market Size and Growth Outlook, 2021- 2030
1.3 Acute Bacterial Skin and Skin Structure Infections Market Growth Opportunities to 2030
1.4 Key Acute Bacterial Skin and Skin Structure Infections Market Trends and Challenges
1.4.1 Acute Bacterial Skin and Skin Structure Infections Market Drivers and Trends
1.4.2 Acute Bacterial Skin and Skin Structure Infections Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Acute Bacterial Skin and Skin Structure Infections Companies
2. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET SIZE OUTLOOK TO 2030
2.1 Acute Bacterial Skin and Skin Structure Infections Market Size Outlook, USD Million, 2021- 2030
2.2 Acute Bacterial Skin and Skin Structure Infections Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.2 Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.5 Europe Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.6 Europe Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.8 North America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.9 North America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.11 South America Pacific Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.12 South America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.14 Middle East Africa Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Acute Bacterial Skin and Skin Structure Infections Market Size Outlook and Revenue Growth Forecasts
6.2 US Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
7. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS COMPANY PROFILES
8.1 Profiles of Leading Acute Bacterial Skin and Skin Structure Infections Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Paratek Pharmaceuticals Inc
Melinta Therapeutics Inc
Allergan PLC
Merck & Co. Inc
Endo Pharmaceuticals Inc
Nabriva Therapeutics PLC
Basilea Pharmaceutica Ltd
Cipher Pharmaceuticals
Menarini Group
Sandoz Inc
Glenmark Pharmaceuticals Ltd
Pfizer Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Acute Bacterial Skin and Skin Structure Infections Market Overview and Key Findings, 2024
1.2 Acute Bacterial Skin and Skin Structure Infections Market Size and Growth Outlook, 2021- 2030
1.3 Acute Bacterial Skin and Skin Structure Infections Market Growth Opportunities to 2030
1.4 Key Acute Bacterial Skin and Skin Structure Infections Market Trends and Challenges
1.4.1 Acute Bacterial Skin and Skin Structure Infections Market Drivers and Trends
1.4.2 Acute Bacterial Skin and Skin Structure Infections Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Acute Bacterial Skin and Skin Structure Infections Companies
2. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET SIZE OUTLOOK TO 2030
2.1 Acute Bacterial Skin and Skin Structure Infections Market Size Outlook, USD Million, 2021- 2030
2.2 Acute Bacterial Skin and Skin Structure Infections Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Infection Type
Hospital-acquired ABSSI
Community-acquired ABSSI
By Route of Administration
Oral
Parenteral
Topical
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.2 Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.5 Europe Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.6 Europe Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.8 North America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.9 North America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.11 South America Pacific Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.12 South America Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Acute Bacterial Skin and Skin Structure Infections Market, 2025
5.14 Middle East Africa Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Acute Bacterial Skin and Skin Structure Infections Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Acute Bacterial Skin and Skin Structure Infections Market Size Outlook and Revenue Growth Forecasts
6.2 US Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Acute Bacterial Skin and Skin Structure Infections Industry Drivers and Opportunities
7. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS COMPANY PROFILES
8.1 Profiles of Leading Acute Bacterial Skin and Skin Structure Infections Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Paratek Pharmaceuticals Inc
Melinta Therapeutics Inc
Allergan PLC
Merck & Co. Inc
Endo Pharmaceuticals Inc
Nabriva Therapeutics PLC
Basilea Pharmaceutica Ltd
Cipher Pharmaceuticals
Menarini Group
Sandoz Inc
Glenmark Pharmaceuticals Ltd
Pfizer Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
